Management of Reactive Cervical Lymph Nodes

Diagnostic Criteria

The American College of Radiology defines lymph nodes <10 mm in short axis as benign, with nodes ≤15 mm consistently demonstrating reactive or benign pathology in studies of incidental lymphadenopathy 1
Reactive cervical lymph nodes may be a response to recent or ongoing upper respiratory infections 1
Reactive cervical lymph nodes may be a response to dental or oropharyngeal inflammatory processes 1

Escalate to further workup if there is progressive enlargement to >15 mm in short axis on subsequent imaging 1
Escalate to further workup if there is development of pathologic features such as loss of fatty hilum, irregular borders, necrosis, or extranodal extension 1
Escalate to further workup if there is development of pathologic features such as loss of fatty hilum, irregular borders, necrosis, or extranodal extension 2

Routine clinical examination during regular healthcare visits is sufficient, with attention to any new symptoms such as persistent enlargement, development of B symptoms, or appearance of a dominant mass 2

The American College of Radiology recommends that lymph nodes with a size below 1 cm in short axis, and a fatty hilum, are considered benign, with a low risk of malignancy 3, 4
Lymph nodes with an oval shape and a longitudinal-transverse ratio favoring benignity, are more likely to be reactive or benign, rather than malignant 5, 6
The American College of Radiology suggests that lymph nodes ≤15 mm in short axis are consistently reactive or benign in studies of incidental lymphadenopathy 4

The American College of Radiology recommends no imaging follow-up for lymph nodes with benign features, such as a fatty hilum and oval shape, as the risk of malignancy is extremely low 3, 4
Biopsy is not indicated for nodes with fatty hilum and benign morphology, as the malignancy risk is extremely low, and biopsy would subject the patient to unnecessary procedural risk 3, 4

The presence of a fatty hilum has a high negative predictive value for malignancy, with its absence having a positive predictive value of 90-93% for malignancy, according to the American College of Radiology 7
A cortical thickness greater than 3 mm is a concerning feature for malignancy, as stated by the American College of Radiology 7, 8
Loss of fatty hilum on follow-up imaging is a red flag that warrants further workup or biopsy, as recommended by the American College of Radiology 7, 9

Progressive enlargement to greater than 15 mm in short axis on subsequent imaging is a red flag that warrants biopsy or further workup 9
Development of pathologic features, including irregular borders, necrosis, or extranodal extension, is a concerning sign for malignancy, although no specific citation is provided in this context, the American College of Radiology likely recommends biopsy in such cases 7

A 2cm axillary lymph node with a thin fatty hilum and thick hypoechoic cortex is suspicious for malignancy and requires ultrasound-guided biopsy, as the combination of size and cortical thickness significantly increases malignancy risk, according to the American College of Radiology 10, 11
The American College of Radiology recommends that suspicious nodes on ultrasound warrant percutaneous biopsy to identify patients at risk for higher tumor burden, with a size of 2cm exceeding the 10mm threshold for benign nodes and the 15mm threshold where malignancy risk substantially increases 10, 11, 12

Core needle biopsy is superior to fine needle aspiration with sensitivity of 88% versus 74%, though both have 100% specificity, and is the preferred method for tissue diagnosis, according to the American College of Radiology 10, 11
Ultrasound-guided FNA is an acceptable alternative if patient cannot discontinue anticoagulation, with sensitivity 52-79% when combined with ultrasound, specificity 98-100%, as recommended by the American College of Radiology 10, 11
On-site cytopathology assessment reduces inadequate sampling rates (5-10%), as stated by the American College of Radiology 10

If breast primary suspected, diagnostic mammography/digital breast tomosynthesis should be performed to identify occult breast malignancy, as recommended by the American College of Radiology 11, 12
If lymphoma or non-breast malignancy suspected, consider PET/CT or CT chest/abdomen/pelvis, although this is not explicitly stated by a specific guideline society in the provided text
If breast cancer already diagnosed, positive biopsy identifies high nodal burden patients who may proceed directly to axillary lymph node dissection rather than sentinel node biopsy, according to the American College of Radiology and the Journal of Clinical Oncology 13, 14

Negative ultrasound with or without biopsy does NOT rule out nodal disease, and ultrasound sensitivity for axillary metastases ranges widely (26-94%), making tissue diagnosis essential, as stated by the American College of Radiology 10, 11, 12, 15, 16
While fatty hilum is reassuring, the size (2cm) and thick cortex create sufficient suspicion to mandate biopsy, according to the American College of Radiology 10
In newly diagnosed breast cancer patients, positive axillary biopsy changes surgical planning from sentinel node biopsy to axillary lymph node dissection, as recommended by the American College of Radiology and the Journal of Clinical Oncology 13, 14